Concussion – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

 Concussion Market Outlook

Thelansis’s “Concussion Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Concussion treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Concussion Overview

A concussion results from a traumatic impact, causing temporary brain function disturbance. It falls under traumatic brain injuries, which range from mild, brief symptoms to prolonged altered consciousness. The injury can stem from direct head impact or indirect forces affecting the brain due to body trauma. Common Concussion Symptoms include Confusion, Headache, Vision issues (blurriness, double vision), Dizziness or imbalance, Nausea or vomiting, Memory lapses, and Ringing in the ears. The underlying mechanism of a concussion is intricate, involving neurochemical and neurometabolic changes rather than just physical damage. Axonal injury from head movement disrupts neurofilament arrangement, releasing electrolytes and neurotransmitters that lead to neurologic dysfunction. Metabolic shifts and reduced cerebral blood flow also contribute. Concussion treatment focuses on support, beginning with reduced physical and cognitive activity and gradual reintegration. Initial diagnosis should consider severe possibilities like spinal injury, intracranial bleeding, or skull fractures. Post-injury, the prognosis is favorable, with symptoms improving within weeks. A complication is post-concussion syndrome (PCS), showing prolonged symptoms. Annually, the USA sees over 300,000 sports-related concussions, particularly prevalent in contact sports. The risk of experiencing a concussion in contact sports can be as high as 19% per year. High school contact sports alone report 62,000 concussions yearly. College football players show 34% with one and 20% with multiple concussions. Estimates suggest that 4-20% of college and high school football players acquire brain injuries in a single season, with a higher risk after a previous concussion.

 

Geography coverage:

G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)

Insights driven by robust research, including:

  • In-depth interviews with leading KOLs and payers
  • Physician surveys
  • RWE analysis for claims and EHR datasets
  • Secondary research (e.g., peer-reviewed journal articles, third-party research databases)

Deliverables format and updates*:

  • Detailed Report (PDF)
  • Market Forecast Model (MS Excel-based automated dashboard)
  • Epidemiology (MS Excel; interactive tool)
  • Executive Insights (PowerPoint presentation)
  • Others: regular updates, customizations, consultant support

*As per Thelansis’s policy, we ensure that we include all the recent updates before releasing the report content and market model.

Salient features of Market Forecast model:

  • 10-year market forecast (2024–2034)
  • Bottom-up patient-based market forecasts validated through the top-down sales methodology
  • Covers clinically and commercially-relevant patient populations/ line of therapies
  • Annualized drug-level sales and patient share projections
  • Utilizes our proprietary Epilansis and Analog tool (e.g., drug uptake and erosion) datasets and conjoint analysis approach
  • Detailed methodology/sources & assumptions
  • Graphical and tabular outputs
  • Users can customize the model based on requirements

Key business questions answered:

  • How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)?
  • How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments?
  • What is the 10-year market outlook for sales and patient share?
  • Which events will have the greatest impact on the market’s trajectory?
  • What insights do interviewed experts provide on current and emerging treatments?
  • Which pipeline products show the most promise, and what is their potential for launch and future positioning?
  • What are the key unmet needs and KOL expectations for target profiles?
  • What key regulatory and payer requirements must be met to secure drug approval and favorable market access?
  • and more…


Read more: Concussion – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Comments

Popular posts from this blog

Retinitis Pigmentosa (RP) – Market Access and Reimbursement Insights Report – 2025

Motor Neurone Disease (MND) – Market Access and Reimbursement Insights Report – 2025

Uncomplicated Gonorrhea – Market Outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2024 To 2034